Activated protein C resistance impact on Syrian candidates for in vitro fertilisation and the benefit of anticoagulation therapy: a retrospective cohort study

References

• Alhalaki W, Altanoukhi IA, Alhalabi M. 2016. The association of activated protein C resistance (aPCR) with recurrent pregnancy loss in Syrian population. International Journal of Pharmaceutical Sciences Review and Research 38:290–295.
   Google Scholar
• American College of Obstetricians and Gynecologists. 2018. ACOG practice bulletin no. 197: inherited thrombophilias in pregnancy. Obstetrics and Gynecology 132:e18–e34.
   PubMed Web of Science ®Google Scholar
• Arachchillage DRJ, Efthymiou M, Mackie IJ, Lawrie AS, Machin SJ, Cohen H, et al. 2014. Anti‐protein C antibodies are associated with resistance to endogenous protein C activation and a severe thrombotic phenotype in antiphospholipid syndrome. Journal of Thrombosis and Haemostasis 12:1801–1809.
   PubMed Web of Science ®Google Scholar
• Aracic N, Roje D, Jakus IA, Bakotin M, Stefanovic V. 2016. The impact of inherited thrombophilia types and low molecular weight heparin treatment on pregnancy complications in women with previous adverse outcome. Yonsei Medical Journal 57:1230–1235. p
   PubMed Web of Science ®Google Scholar
• Bahadur G, Homburg R, Bosmans JE, Huirne JAF, Hinstridge P, Jayaprakasan K, et al. 2020. Observational retrospective study of UK national success, risks and costs for 319,105 IVF/ICSI and 30,669 IUI treatment cycles. BMJ Open 10:e034566.
   PubMed Web of Science ®Google Scholar
• Balasch J, Reverter JC, Fabregues F, Tassies D, Rafel M, Creus M, et al. 1997. First-trimester repeated abortion is not associated with activated protein C resistance. Human Reproduction 12:1094–1097.
   PubMed Web of Science ®Google Scholar
• Centres for Disease and Prevention (CDC). 2019. [cited 2021 April 5]. Available from: https://www.cdc.gov/art/whatis.html.
   Google Scholar
• Curvers J, Thomassen MCLGD, Rimmer J, Hamulyak K, van der Meer J, Tans G, et al. 2002. Effects of hereditary and acquired risk factors of venous thrombosis on a thrombin generation-based APC resistance test. Thrombosis and Haemostasis 88:5–11.
   PubMed Web of Science ®Google Scholar
• Dang T-T, Phung TM, Le H, Nguyen T-B-V, Nguyen TS, Nguyen TLH, et al. 2019. Preimplantation genetic testing of aneuploidy by next generation sequencing: association of maternal age and chromosomal abnormalities of blastocyst. Open Access Macedonian Journal of Medical Sciences 7:4427–4431.
   PubMedGoogle Scholar
• Di Nisio M, et al. 2011. Thrombophilia and outcomes of assisted reproduction technologies: a systematic review and meta-analysis. Blood, The Journal of the American Society of Hematology 118:2670–2678.
   Google Scholar
• Gardiner C, Cohen H, Jenkins A, Machin SJ, Mackie IJ. 2006. Detection of acquired resistance to activated protein C associated with antiphospholipid antibodies using a novel clotting assay. Blood Coagulation & Fibrinolysis 17:477–483.
   PubMed Web of Science ®Google Scholar
• Hamulyák EN, Scheres LJJ, Marijnen MC, Goddijn M, Middeldorp S. 2020. Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss. Cochrane Database of Systematic Reviews 5:CD012852.
   PubMedGoogle Scholar
• Karadağ C, Akar B, Gönenç G, Aslancan R, Yılmaz N, Çalışkan E, et al. 2020. Aspirin, low molecular weight heparin, or both in preventing pregnancy complications in women with recurrent pregnancy loss and factor V Leiden mutation. The Journal of Maternal-Fetal & Neonatal Medicine 33:1934–1939.
   PubMed Web of Science ®Google Scholar
• Kuliev A, Cieslak J, Ilkevitch Y, Verlinsky Y. 2003. Chromosomal abnormalities in a series of 6733 human oocytes in preimplantation diagnosis for age-related aneuploidies. Reproductive Biomedicine Online 6:54–59.
   PubMedGoogle Scholar
• MedlinePlus. 2021. [cited 2021 April 3]. Available from: https://medlineplus.gov/assistedreproductivetechnology.html.
   Google Scholar
• Mello G, Parretti E, Martini E, Mecacci F, La Torre P, Cioni R, et al. 1999. Usefulness of screening for congenital or acquired hemostatic abnormalities in women with previous complicated pregnancies. Pathophysiology of Haemostasis and Thrombosis 29:197–203.
   Google Scholar
• Navot D, Bergh RA, Williams MA, Garrisi GJ, Guzman I, Sandler B, et al. 1991. Poor oocyte quality rather than implantation failure as a cause of age-related decline in female fertility. The Lancet 337:1375–1377.
   PubMed Web of Science ®Google Scholar
• Nichols WL, Heit JA. 1996. Activated protein C resistance and thrombosis. Mayo Clinic Proceedings 71:897–898.
   PubMed Web of Science ®Google Scholar
• Nicolaes GA, Dahlbäck B. 2003. Congenital and acquired activated protein C resistance. Seminars in Vascular Medicine 3:33–46.
   PubMedGoogle Scholar
• Qublan H, Amarin Z, Dabbas M, Farraj A-E, Beni-Merei Z, Al-Akash H, et al. 2008. Low-molecular-weight heparin in the treatment of recurrent IVF–ET failure and thrombophilia: a prospective randomized placebo-controlled trial. Human Fertility 11:246–253.
   PubMedGoogle Scholar
• Qublan HS, Eid SS, Ababneh HA, Amarin ZO, Smadi AZ, Al-Khafaji FF, et al. 2006. Acquired and inherited thrombophilia: implication in recurrent IVF and embryo transfer failure. Human Reproduction 21:2694–2698. p
   PubMed Web of Science ®Google Scholar
• Quenhenberger P, Handler S, Mannhalter C, Pabinger-Fasching I, Speiser W. 2000. Evaluation of a highly specific functional test for the detection of factor V Leiden. International Journal of Clinical & Laboratory Research 30:113–117.
   PubMedGoogle Scholar
• Rai R, Shlebak A, Cohen H, Backos M, Holmes Z, Marriott K, et al. 2001. Factor V Leiden and acquired activated protein C resistance among 1000 women with recurrent miscarriage. Human Reproduction 16:961–965.
   PubMed Web of Science ®Google Scholar
• Rey E, Kahn SR, David M, Shrier I. 2003. Thrombophilic disorders and fetal loss: a meta-analysis. The Lancet 361:901–908.
   PubMed Web of Science ®Google Scholar
• Rittenberg V, Seshadri S, Sunkara SK, Sobaleva S, Oteng-Ntim E, El-Toukhy T, et al. 2011. Effect of body mass index on IVF treatment outcome: an updated systematic review and meta-analysis. Reproductive Biomedicine Online 23:421–439.
   PubMed Web of Science ®Google Scholar
• Sarig G, Michaeli Y, Lanir N, Brenner B, Haim N. 2005. Mechanisms for acquired activated protein C resistance in cancer patients. Journal of Thrombosis and Haemostasis 3:589–590.
   PubMed Web of Science ®Google Scholar
• Shaulov T, Sierra S, Sylvestre C. 2020. Recurrent implantation failure: a CFAS guideline. Reproductive BioMedicine Online 41:819–833.
   PubMed Web of Science ®Google Scholar
• Skelley JW, White CW, Thomason AR. 2017. The use of direct oral anticoagulants in inherited thrombophilia. Journal of Thrombosis and Thrombolysis 43:24–30.
   PubMed Web of Science ®Google Scholar
• Tal J, Schliamser LM, Leibovitz Z, Ohel G, Attias D. 1999. A possible role for activated protein C resistance in patients with first and second trimester pregnancy failure. Human Reproduction 14:1624–1627.
   PubMed Web of Science ®Google Scholar
• Tan X, Yu Z, Sao J, Chen L, Shen Y, Ding J, et al. 2016. Association between in vitro fertilization outcomes and inherited thrombophilias: a meta-analysis. Journal of Assisted Reproduction and Genetics 33:1093–1098.
   PubMed Web of Science ®Google Scholar
• Winkler A. 2019. Transfusion medicine and Hemostasis. 3rd ed. Amsterdam, Netherlands: Elsevier. p. 899–901.
   Google Scholar
• Yovich JL. 2020. Founding pioneers of IVF update: innovative researchers generating livebirths by 1982. Reproductive Biology 20:111–113.
   PubMed Web of Science ®Google Scholar
• Zeyneloglu HB, Arici A, Olive DL. 1998. Adverse effects of hydrosalpinx on pregnancy rates after in vitro fertilization–embryo transfer. Fertility and Sterility 70:492–499.
   PubMed Web of Science ®Google Scholar